0001104659-15-014916.txt : 20150227 0001104659-15-014916.hdr.sgml : 20150227 20150227113022 ACCESSION NUMBER: 0001104659-15-014916 CONFORMED SUBMISSION TYPE: N-Q PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20141231 FILED AS OF DATE: 20150227 DATE AS OF CHANGE: 20150227 EFFECTIVENESS DATE: 20150227 FILER: COMPANY DATA: COMPANY CONFORMED NAME: COLUMBIA FUNDS SERIES TRUST I CENTRAL INDEX KEY: 0000773757 IRS NUMBER: 363376651 STATE OF INCORPORATION: MA FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: N-Q SEC ACT: 1940 Act SEC FILE NUMBER: 811-04367 FILM NUMBER: 15655912 BUSINESS ADDRESS: STREET 1: 225 FRANKLIN STREET CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 8003382550 MAIL ADDRESS: STREET 1: 225 FRANKLIN STREET CITY: BOSTON STATE: MA ZIP: 02110 FORMER COMPANY: FORMER CONFORMED NAME: COLUMBIA FUNDS TRUST IX DATE OF NAME CHANGE: 20031107 FORMER COMPANY: FORMER CONFORMED NAME: LIBERTY STEIN ROE FUNDS MUNICIPAL TRUST DATE OF NAME CHANGE: 19991025 FORMER COMPANY: FORMER CONFORMED NAME: STEINROE MUNICIPAL TRUST DATE OF NAME CHANGE: 19920703 0000773757 S000021575 Columbia Select Large Cap Growth Fund C000061818 Class A Shares ELGAX C000061819 Class C Shares ELGCX C000061820 Class R Shares URLGX C000061821 Class Z Shares UMLGX C000094709 Class I Shares CSPIX C000094710 Class W Shares CSLWX C000122687 Class R4 CSRRX C000122688 Class R5 CGTRX C000122689 Class Y CCWRX 0000773757 S000021576 Columbia Pacific/Asia Fund C000061822 Class A Shares CASAX C000061823 Class C Shares CASCX C000061824 Class Z Shares USPAX C000094711 Class I Shares CPCIX C000117689 Class W CPAWX C000126475 Class R4 CPRAX 0000773757 S000036204 Active Portfolios Multi-Manager Growth Fund C000110855 Class A CSLGX N-Q 1 a15-2258_1nq.htm N-Q

 

 

 

OMB APPROVAL

 

 

OMB Number:

3235-0578

 

 

Expires:

January 31, 2016

 

UNITED STATES

Estimated average burden hours per response. . . . . . . . . . . . . 10.5

 

SECURITIES AND EXCHANGE COMMISSION

 

 

Washington, D.C. 20549

 

 

FORM N-Q

 

QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED
MANAGEMENT INVESTMENT COMPANY

 

Investment Company Act file number

811-04367

 

Columbia Funds Series Trust I

(Exact name of registrant as specified in charter)

 

225 Franklin Street, Boston, MA

 

02110

(Address of principal executive offices)

 

(Zip code)

 

Ryan Larrenaga

c/o Columbia Management Investment Advisers, LLC

225 Franklin Street

Boston, MA 02110

(Name and address of agent for service)

 

Registrant’s telephone number, including area code:

(800) 345-6611

 

 

Date of fiscal year end:

March 31

 

 

Date of reporting period:

December 31, 2014

 

 



 

Item 1. Schedule of Investments.

 



 

Portfolio of Investments

Active Portfolios® Multi-Manager Growth Fund

December 31, 2014 (Unaudited)

(Percentages represent value of investments compared to net assets)

 


Issuer

 

Shares

 

Value

 

 

 

 

 

 

 

Common Stocks 99.4%

 

 

 

 

 

CONSUMER DISCRETIONARY 18.5%

 

 

 

 

 

Automobiles 2.0%

 

 

 

 

 

Tesla Motors, Inc. (a)

 

162,388

 

$

36,116,715

 

Hotels, Restaurants & Leisure 0.3%

 

 

 

 

 

Yum! Brands, Inc.

 

81,821

 

5,960,660

 

Internet & Catalog Retail 8.1%

 

 

 

 

 

Amazon.com, Inc. (a)

 

238,314

 

73,960,750

 

Priceline Group, Inc. (The) (a)

 

63,536

 

72,444,383

 

Total

 

 

 

146,405,133

 

Specialty Retail 3.1%

 

 

 

 

 

Lowe’s Companies, Inc.

 

137,341

 

9,449,061

 

Tractor Supply Co.

 

588,198

 

46,361,766

 

Total

 

 

 

55,810,827

 

Textiles, Apparel & Luxury Goods 5.0%

 

 

 

 

 

Michael Kors Holdings Ltd. (a)

 

595,996

 

44,759,300

 

Nike, Inc., Class B

 

463,670

 

44,581,870

 

Total

 

 

 

89,341,170

 

TOTAL CONSUMER DISCRETIONARY

 

 

 

333,634,505

 

CONSUMER STAPLES 2.5%

 

 

 

 

 

Beverages 1.4%

 

 

 

 

 

Coca-Cola Co. (The)

 

228,351

 

9,640,979

 

Monster Beverage Corp. (a)

 

105,610

 

11,442,844

 

SABMiller PLC, ADR

 

103,013

 

5,311,350

 

Total

 

 

 

26,395,173

 

Food Products 0.5%

 

 

 

 

 

Danone SA, ADR

 

695,894

 

9,058,452

 

Household Products 0.6%

 

 

 

 

 

Procter & Gamble Co. (The)

 

112,523

 

10,249,720

 

TOTAL CONSUMER STAPLES

 

 

 

45,703,345

 

ENERGY 5.7%

 

 

 

 

 

Energy Equipment & Services 2.6%

 

 

 

 

 

FMC Technologies, Inc. (a)

 

811,400

 

38,005,976

 

Schlumberger Ltd.

 

93,906

 

8,020,512

 

Total

 

 

 

46,026,488

 

Oil, Gas & Consumable Fuels 3.1%

 

 

 

 

 

Cabot Oil & Gas Corp.

 

1,886,740

 

55,866,371

 

TOTAL ENERGY

 

 

 

101,892,859

 

 

Issuer

 

Shares

 

Value

 

 

 

 

 

 

 

Common Stocks (continued)

 

 

 

FINANCIALS 0.9%

 

 

 

 

 

Capital Markets 0.6%

 

 

 

 

 

Greenhill & Co., Inc.

 

49,539

 

$

2,159,901

 

SEI Investments Co.

 

210,524

 

8,429,381

 

Total

 

 

 

10,589,282

 

Consumer Finance 0.3%

 

 

 

 

 

American Express Co.

 

53,584

 

4,985,455

 

TOTAL FINANCIALS

 

 

 

15,574,737

 

HEALTH CARE 23.6%

 

 

 

 

 

Biotechnology 15.2%

 

 

 

 

 

Alexion Pharmaceuticals, Inc. (a)

 

228,495

 

42,278,430

 

Amgen, Inc.

 

51,514

 

8,205,665

 

Biogen Idec, Inc. (a)

 

167,630

 

56,902,003

 

Celgene Corp. (a)

 

507,944

 

56,818,616

 

Pharmacyclics, Inc. (a)

 

410,361

 

50,170,736

 

Vertex Pharmaceuticals, Inc. (a)

 

504,900

 

59,982,120

 

Total

 

 

 

274,357,570

 

Health Care Equipment & Supplies 0.7%

 

 

 

Varian Medical Systems, Inc. (a)

 

89,408

 

7,734,686

 

Zimmer Holdings, Inc.

 

45,434

 

5,153,124

 

Total

 

 

 

12,887,810

 

Life Sciences Tools & Services 3.7%

 

 

 

 

 

Illumina, Inc. (a)

 

356,544

 

65,810,892

 

Pharmaceuticals 4.0%

 

 

 

 

 

Bristol-Myers Squibb Co.

 

885,850

 

52,291,726

 

Merck & Co., Inc.

 

77,674

 

4,411,106

 

Novartis AG, ADR

 

96,351

 

8,927,884

 

Novo Nordisk A/S, ADR

 

174,528

 

7,386,025

 

Total

 

 

 

73,016,741

 

TOTAL HEALTH CARE

 

 

 

426,073,013

 

INDUSTRIALS 6.2%

 

 

 

 

 

Aerospace & Defense 2.1%

 

 

 

 

 

Precision Castparts Corp.

 

154,338

 

37,176,937

 

Air Freight & Logistics 1.0%

 

 

 

 

 

Expeditors International of Washington, Inc.

 

197,550

 

8,812,705

 

United Parcel Service, Inc., Class B

 

84,317

 

9,373,521

 

Total

 

 

 

18,186,226

 



 


Issuer

 

Shares

 

Value

 

 

 

 

 

 

 

Common Stocks (continued)

 

 

 

INDUSTRIALS (CONTINUED)

 

 

 

 

 

Trading Companies & Distributors 3.1%

 

 

 

 

Fastenal Co.

 

1,189,553

 

$

56,575,141

 

TOTAL INDUSTRIALS

 

 

 

111,938,304

 

INFORMATION TECHNOLOGY 39.7%

 

 

 

 

 

Communications Equipment 1.5%

 

 

 

 

 

Cisco Systems, Inc.

 

565,242

 

15,722,206

 

QUALCOMM, Inc.

 

152,895

 

11,364,685

 

Total

 

 

 

27,086,891

 

Internet Software & Services 18.7%

 

 

 

 

 

Alibaba Group Holding Ltd., ADR (a)

 

494,693

 

51,418,390

 

Baidu, Inc., ADR (a)

 

230,396

 

52,523,376

 

Facebook, Inc., Class A (a)

 

855,407

 

66,738,854

 

Google, Inc., Class A (a)

 

11,757

 

6,238,970

 

Google, Inc., Class C (a)

 

11,755

 

6,187,832

 

LinkedIn Corp., Class A (a)

 

301,635

 

69,288,576

 

MercadoLibre, Inc.

 

264,440

 

33,761,055

 

Twitter, Inc. (a)

 

1,400,240

 

50,226,609

 

Total

 

 

 

336,383,662

 

IT Services 7.1%

 

 

 

 

 

Automatic Data Processing, Inc.

 

32,272

 

2,690,516

 

Cognizant Technology Solutions Corp., Class A (a)

 

917,082

 

48,293,538

 

Visa, Inc., Class A

 

292,304

 

76,642,109

 

Total

 

 

 

127,626,163

 

Semiconductors & Semiconductor Equipment 2.8%

 

 

Altera Corp.

 

18,569

 

685,939

 

Analog Devices, Inc.

 

22,196

 

1,232,322

 

ARM Holdings PLC, ADR

 

1,040,557

 

48,177,789

 

Total

 

 

 

50,096,050

 

 

Issuer

 

Shares

 

Value

 

 

 

 

 

 

 

Common Stocks (continued)

 

 

INFORMATION TECHNOLOGY (CONTINUED)

 

 

 

Software 9.6%

 

 

 

 

 

Autodesk, Inc. (a)

 

144,194

 

$

8,660,292

 

Factset Research Systems, Inc.

 

45,865

 

6,455,499

 

Microsoft Corp.

 

150,041

 

6,969,404

 

Oracle Corp.

 

293,872

 

13,215,424

 

salesforce.com, Inc. (a)

 

867,024

 

51,423,193

 

Splunk, Inc. (a)

 

776,457

 

45,772,140

 

VMware, Inc., Class A (a)

 

504,324

 

41,616,817

 

Total

 

 

 

174,112,769

 

TOTAL INFORMATION TECHNOLOGY

 

 

 

715,305,535

 

MATERIALS 2.3%

 

 

 

 

 

Chemicals 2.3%

 

 

 

 

 

Monsanto Co.

 

343,440

 

41,030,777

 

TOTAL MATERIALS

 

 

 

41,030,777

 

Total Common Stocks
(Cost: $1,437,666,114)

 

 

 

$

1,791,153,075

 

 

 

 

 

 

 

 

 

Shares

 

Value

 

 

 

 

 

 

 

Money Market Funds 0.5%

 

 

 

 

Columbia Short-Term Cash Fund, 0.115% (b)(c)

 

8,267,744

 

$

8,267,744

 

Total Money Market Funds
(Cost: $8,267,744)

 

 

 

$

8,267,744

 

Total Investments

 

 

 

 

 

(Cost: $1,445,933,858) (d)

 

 

 

$

1,799,420,819(e)

 

Other Assets & Liabilities, Net

 

 

 

2,687,667

 

Net Assets

 

 

 

$

1,802,108,486

 


 

Notes to Portfolio of Investments

 

 

 

(a)

Non-income producing.

(b)

The rate shown is the seven-day current annualized yield at December 31, 2014.

(c)

As defined in the Investment Company Act of 1940, an affiliated company is one in which the Fund owns 5% or more of the company’s outstanding voting securities, or a company which is under common ownership or control with the Fund. Holdings and transactions in these affiliated companies during the period ended December 31, 2014, are as follows:

 

Issuer

 

Beginning
Cost ($)

 

Purchase
Cost ($)

 

Proceeds From
Sales ($)

 

Ending Cost ($)

 

Dividends —
Affiliated Issuers ($)

 

Value ($)

 

Columbia Short-Term Cash Fund

 

9,613,880

 

423,314,322

 

(424,660,458

)

8,267,744

 

23,180

 

8,267,744

 

 

(d)

At December 31, 2014, the cost of securities for federal income tax purposes was approximately $1,445,934,000 and the approximate aggregate gross unrealized appreciation and depreciation based on that cost was:

 

Unrealized Appreciation

 

$

383,905,000

 

Unrealized Depreciation

 

(30,418,000

)

Net Unrealized Appreciation

 

$

353,487,000

 

 


 

(e)

Investments are valued using policies described in the notes to financial statements in the most recent shareholder report.

 

Abbreviation Legend

 

ADR

American Depositary Receipt

 

Fair Value Measurements

 

 

Generally accepted accounting principles (GAAP) require disclosure regarding the inputs and valuation techniques used to measure fair value and any changes in valuation inputs or techniques. In addition, investments shall be disclosed by major category.

 

The Fund categorizes its fair value measurements according to a three-level hierarchy that maximizes the use of observable inputs and minimizes the use of unobservable inputs by prioritizing that the most observable input be used when available.  Observable inputs are those that market participants would use in pricing an investment based on market data obtained from sources independent of the reporting entity. Unobservable inputs are those that reflect the Fund’s assumptions about the information market participants would use in pricing an investment. An investment’s level within the fair value hierarchy is based on the lowest level of any input that is deemed significant to the asset or liability’s fair value measurement. The input levels are not necessarily an indication of the risk or liquidity associated with investments at that level. For example, certain U.S. government securities are generally high quality and liquid, however, they are reflected as Level 2 because the inputs used to determine fair value may not always be quoted prices in an active market.

 

Fair value inputs are summarized in the three broad levels listed below:

 

·                             Level 1 - Valuations based on quoted prices for investments in active markets that the Fund has the ability to access at the measurement date (including NAV for open-end mutual funds).  Valuation adjustments are not applied to Level 1 investments.

 

·                            Level 2 – Valuations based on other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risks, etc.).

 

·                            Level 3 – Valuations based on significant unobservable inputs (including the Fund’s own assumptions and judgment in determining the fair value of investments).

 

Inputs that are used in determining fair value of an investment may include price information, credit data, volatility statistics, and other factors. These inputs can be either observable or unobservable. The availability of observable inputs can vary between investments, and is affected by various factors such as the type of investment, and the volume and level of activity for that investment or similar investments in the marketplace. The inputs will be considered by the Investment Manager, along with any other relevant factors in the calculation of an investment’s fair value. The Fund uses prices and inputs that are current as of the measurement date, which may include periods of market dislocations. During these periods, the availability of prices and inputs may be reduced for many investments. This condition could cause an investment to be reclassified between the various levels within the hierarchy.

 

Investments falling into the Level 3 category are primarily supported by quoted prices from brokers and dealers participating in the market for those investments.  However, these may be classified as Level 3 investments due to lack of market transparency and corroboration to support these quoted prices.  Additionally, valuation models may be used as the pricing source for any remaining investments classified as Level 3. These models may rely on one or more significant unobservable inputs and/or significant assumptions by the Investment Manager.  Inputs used in valuations may include, but are not limited to, financial statement analysis, capital account balances, discount rates and estimated cash flows, and comparable company data.

 

Under the direction of the Fund’s Board of Trustees (the Board), the Investment Manager’s Valuation Committee (the Committee) is responsible for overseeing the valuation procedures approved by the Board. The Committee consists of voting and non-voting members from various groups within the Investment Manager’s organization, including operations and accounting, trading and investments, compliance, risk management and legal.

 

The Committee meets at least monthly to review and approve valuation matters, which may include a description of specific valuation determinations, data regarding pricing information received from approved pricing vendors and brokers and the results of Board-approved valuation control policies and procedures (the Policies).  The Policies address, among other things, instances when market quotations are or are not readily available, including recommendations of third party pricing vendors and a determination of appropriate pricing methodologies; events that require specific valuation determinations and assessment of fair value techniques; securities with a potential for stale pricing, including those that are illiquid, restricted, or in default; and the effectiveness of third party pricing vendors, including periodic reviews of vendors.  The Committee meets more frequently, as needed, to discuss additional valuation matters, which may include the need to review back-testing results, review time-sensitive information or approve related valuation actions.  The Committee reports to the Board, with members of the Committee meeting with the Board at each of its regularly scheduled meetings to discuss valuation matters and actions during the period, similar to those described earlier.

 


 

For investments categorized as Level 3, the Committee monitors information similar to that described above, which may include: (i) data specific to the issuer or comparable issuers, (ii) general market or specific sector news and (iii) quoted prices and specific or similar security transactions.  The Committee considers this data and any changes from prior periods in order to assess the reasonableness of observable and unobservable inputs, any assumptions or internal models used to value those securities and changes in fair value.  This data is also used to corroborate, when available, information received from approved pricing vendors and brokers.  Various factors impact the frequency of monitoring this information (which may occur as often as daily). However, the Committee may determine that changes to inputs, assumptions and models are not required as a result of the monitoring procedures performed.

 

The following table is a summary of the inputs used to value the Fund’s investments at December 31, 2014:

 

Description

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

 

 

 

 

 

Quoted Prices in

 

 

Other Significant

 

 

Significant

 

 

 

 

 

 

 

Active Markets for

 

 

Observable

 

 

Unobservable

 

 

 

 

 

 

 

Identical Assets ($)

 

 

Inputs ($)

 

 

Inputs ($)

 

 

Total ($)

 

Equity Securities

 

 

 

 

 

 

 

 

 

 

 

 

 

Common Stocks

 

 

 

 

 

 

 

 

 

 

 

 

 

Consumer Discretionary

 

 

333,634,505

 

 

 

 

 

 

333,634,505

 

Consumer Staples

 

 

45,703,345

 

 

 

 

 

 

45,703,345

 

Energy

 

 

101,892,859

 

 

 

 

 

 

101,892,859

 

Financials

 

 

15,574,737

 

 

 

 

 

 

15,574,737

 

Health Care

 

 

426,073,013

 

 

 

 

 

 

426,073,013

 

Industrials

 

 

111,938,304

 

 

 

 

 

 

111,938,304

 

Information Technology

 

 

715,305,535

 

 

 

 

 

 

715,305,535

 

Materials

 

 

41,030,777

 

 

 

 

 

 

41,030,777

 

Total Equity Securities

 

 

1,791,153,075

 

 

 

 

 

 

1,791,153,075

 

Mutual Funds

 

 

 

 

 

 

 

 

 

 

 

 

 

Money Market Funds

 

 

8,267,744

 

 

 

 

 

 

8,267,744

 

Total Mutual Funds

 

 

8,267,744

 

 

 

 

 

 

8,267,744

 

Total

 

 

1,799,420,819

 

 

 

 

 

 

1,799,420,819

 

 

See the Portfolio of Investments for all investment classifications not indicated in the table.

 

There were no transfers of financial assets between levels during the period.

 

 


 

Portfolio of Investments

Columbia Pacific/Asia Fund

 

December 31, 2014 (Unaudited)

 

(Percentages represent value of investments compared to net assets)


 

Issuer

 

Shares

 

Value

 

 

 

 

 

 

 

Common Stocks 96.0%

 

 

 

 

 

AUSTRALIA 10.1%

 

 

 

 

 

Amcor Ltd.

 

292,538

 

$

3,218,601

 

Australia and New Zealand Banking Group Ltd.

 

110,556

 

2,876,663

 

BHP Billiton Ltd.

 

141,413

 

3,343,376

 

Commonwealth Bank of Australia

 

71,026

 

4,934,799

 

Macquarie Group Ltd.

 

65,270

 

3,077,928

 

Telstra Corp., Ltd.

 

958,049

 

4,651,163

 

Wesfarmers Ltd.

 

46,589

 

1,577,394

 

Westpac Banking Corp.

 

122,122

 

3,284,568

 

Total

 

 

 

26,964,492

 

CHINA 16.0%

 

 

 

 

 

Alibaba Group Holding Ltd., ADR (a)

 

13,283

 

1,380,635

 

Baidu, Inc., ADR (a)

 

6,216

 

1,417,061

 

China Biologic Products, Inc. (a)

 

32,955

 

2,215,565

 

China Mobile Ltd.

 

337,000

 

3,947,196

 

Chongqing Changan Automobile Co., Ltd., Class B

 

480,900

 

1,088,973

 

CNOOC Ltd.

 

1,801,000

 

2,435,257

 

CSPC Pharmaceutical Group Ltd.

 

1,310,000

 

1,151,444

 

Guangdong Investment Ltd.

 

2,822,000

 

3,675,498

 

Haitong Securities Co., Ltd., Class H

 

636,000

 

1,587,383

 

Industrial & Commercial Bank of China Ltd., Class H

 

7,471,100

 

5,455,340

 

Luthai Textile Co., Ltd., Class B

 

1,076,720

 

1,428,749

 

Luye Pharma Group Ltd. (a)

 

1,258,500

 

1,608,629

 

Pax Global Technology Ltd. (a)

 

1,884,000

 

1,929,791

 

Ping An Insurance Group Co. of China Ltd., Class H

 

223,500

 

2,263,059

 

Tencent Holdings Ltd.

 

318,700

 

4,611,248

 

Vipshop Holdings Ltd., ADS (a)

 

63,696

 

1,244,620

 

WuXi PharmaTech (Cayman), Inc. ADR (a)

 

77,401

 

2,606,092

 

Zhuzhou CSR Times Electric Co., Ltd., Class H

 

452,000

 

2,637,514

 

Total

 

 

 

42,684,054

 

HONG KONG 4.8%

 

 

 

 

 

AIA Group Ltd.

 

467,200

 

2,576,827

 

Cheung Kong Holdings Ltd.

 

231,000

 

3,868,516

 

Hutchison Whampoa Ltd.

 

209,000

 

2,389,198

 

Jardine Matheson Holdings Ltd.

 

26,000

 

1,579,874

 

Sands China Ltd.

 

474,800

 

2,311,395

 

Total

 

 

 

12,725,810

 

INDIA 6.7%

 

 

 

 

 

Asian Paints Ltd.

 

124,458

 

1,475,244

 

Bank of Baroda

 

90,855

 

1,551,560

 

HCL Technologies Ltd.

 

103,059

 

2,602,801

 

 

Issuer

 

Shares

 

Value

 

 

 

 

 

 

 

Common Stocks (continued)

 

 

 

 

 

INDIA (CONTINUED)

 

 

 

 

 

HDFC Bank Ltd., ADR

 

67,640

 

$

3,432,730

 

Lupin Ltd.

 

109,915

 

2,483,360

 

Motherson Sumi Systems Ltd.

 

400,444

 

2,883,970

 

Tata Motors Ltd.

 

239,802

 

1,875,862

 

UPL Ltd.

 

255,526

 

1,397,687

 

Total

 

 

 

17,703,214

 

INDONESIA 1.9%

 

 

 

 

 

PT Bank Rakyat Indonesia Persero Tbk

 

3,286,100

 

3,088,870

 

PT Matahari Department Store Tbk

 

1,579,900

 

1,903,718

 

Total

 

 

 

4,992,588

 

JAPAN 37.6%

 

 

 

 

 

Alps Electric Co., Ltd.

 

120,700

 

2,281,519

 

Aozora Bank Ltd.

 

762,000

 

2,358,805

 

Astellas Pharma, Inc.

 

308,800

 

4,299,146

 

Central Japan Railway Co.

 

26,200

 

3,926,760

 

COMSYS Holdings Corp.

 

201,500

 

2,756,474

 

CYBERDYNE, Inc. (a)

 

32,500

 

825,412

 

Daiichikosho Co., Ltd.

 

114,700

 

3,109,888

 

Daikin Industries Ltd.

 

32,400

 

2,077,620

 

Doshisha Co., Ltd.

 

64,000

 

903,681

 

Fuji Heavy Industries Ltd.

 

145,800

 

5,159,277

 

Hoshizaki Electric Co., Ltd.

 

51,500

 

2,481,679

 

Hoya Corp.

 

66,400

 

2,245,969

 

Hulic REIT, Inc.

 

871

 

1,321,989

 

Invincible Investment Corp.

 

3,274

 

1,371,307

 

Iriso Electronics Co., Ltd.

 

16,600

 

881,023

 

ITOCHU Corp.

 

120,500

 

1,286,349

 

KDDI Corp.

 

78,200

 

4,912,841

 

Keyence Corp.

 

5,000

 

2,227,974

 

M3, Inc.

 

134,100

 

2,243,762

 

Mazda Motor Corp.

 

70,100

 

1,683,492

 

Mitsubishi UFJ Financial Group, Inc.

 

228,800

 

1,257,080

 

Mitsui Fudosan Co., Ltd.

 

43,000

 

1,153,069

 

Nakanishi, Inc.

 

62,100

 

2,636,315

 

Nidec Corp.

 

34,200

 

2,208,829

 

Nihon M&A Center, Inc.

 

86,200

 

2,596,858

 

Omron Corp.

 

70,300

 

3,144,905

 

ORIX Corp.

 

266,790

 

3,356,965

 

PeptiDream, Inc. (a)

 

9,600

 

834,354

 

Raito Kogyo Co., Ltd.

 

127,000

 

1,103,531

 

San-A Co., Ltd.

 

99,600

 

3,365,512

 

Seiko Epson Corp.

 

57,200

 

2,393,489

 

Shinmaywa Industries Ltd.

 

269,000

 

2,534,349

 

SoftBank Corp.

 

36,400

 

2,166,648

 

Sumitomo Mitsui Financial Group, Inc.

 

90,800

 

3,282,667

 


 

Issuer

 

Shares

 

Value

 

 

 

 

 

 

 

Common Stocks (continued)

 

 

 

 

 

JAPAN (CONTINUED)

 

 

 

 

 

Sun Frontier Fudousan Co., Ltd.

 

172,300

 

$

1,583,429

 

Tanseisha Co., Ltd.

 

149,000

 

1,012,081

 

Temp Holdings Co., Ltd.

 

43,100

 

1,352,446

 

Tokai Tokyo Financial Holdings, Inc.

 

372,700

 

2,543,225

 

Tokyo Gas Co., Ltd.

 

503,000

 

2,714,019

 

Toyo Tire & Rubber Co., Ltd.

 

188,900

 

3,706,922

 

Toyota Motor Corp.

 

108,700

 

6,773,901

 

Total

 

 

 

100,075,561

 

MALAYSIA 1.0%

 

 

 

 

 

Tenaga Nasional Bhd

 

675,200

 

2,659,245

 

PHILIPPINES 3.7%

 

 

 

 

 

GT Capital Holdings, Inc.

 

143,800

 

3,293,767

 

Metropolitan Bank & Trust Co.

 

954,314

 

1,759,574

 

Robinsons Retail Holdings, Inc.

 

918,070

 

1,553,633

 

Universal Robina Corp.

 

269,620

 

1,175,513

 

Vista Land & Lifescapes, Inc.

 

12,064,550

 

1,939,099

 

Total

 

 

 

9,721,586

 

SINGAPORE 3.1%

 

 

 

 

 

DBS Group Holdings Ltd.

 

322,000

 

4,984,988

 

Frasers Centrepoint Ltd.

 

1,476,000

 

1,877,518

 

Wing Tai Holdings Ltd.

 

1,024,000

 

1,260,853

 

Total

 

 

 

8,123,359

 

SOUTH KOREA 4.3%

 

 

 

 

 

Samsung Electronics Co., Ltd.

 

6,374

 

7,663,106

 

SK Telecom Co., Ltd.

 

15,154

 

3,706,563

 

Total

 

 

 

11,369,669

 

TAIWAN 4.6%

 

 

 

 

 

Gigabyte Technology Co., Ltd.

 

1,526,000

 

1,771,379

 

MediaTek, Inc.

 

126,000

 

1,831,716

 

Pegatron Corp.

 

684,000

 

1,563,445

 

Taiwan Semiconductor Manufacturing Co., Ltd., ADR

 

252,168

 

5,643,520

 

Tong Hsing Electronic Industries Ltd.

 

453,000

 

1,550,853

 

Total

 

 

 

12,360,913

 

 

 

Issuer

 

Shares

 

Value

 

 

 

 

 

 

 

Common Stocks (continued)

 

 

 

 

 

THAILAND 2.2%

 

 

 

 

 

Bangkok Expressway PCL, Foreign Registered Shares

 

2,122,500

 

$

2,548,290

 

Hemaraj Land and Development PCL, Foreign Registered Shares

 

7,174,600

 

953,468

 

Kasikornbank PCL, Foreign Registered Shares

 

333,400

 

2,307,885

 

Total

 

 

 

5,809,643

 

Total Common Stocks
(Cost: $208,053,632)

 

 

 

$

255,190,134

 

 

 

 

 

 

 

 

 

Shares

 

Value

 

 

 

 

 

 

 

Exchange-Traded Funds 1.3%

 

 

 

WisdomTree Japan Hedged Equity Fund

 

68,480

 

3,371,270

 

Total Exchange-Traded Funds
(Cost: $3,699,294)

 

 

 

$

3,371,270

 

 

 

 

 

 

 

 

 

Shares

 

Value

 

 

 

 

 

 

 

Money Market Funds 2.9%

 

 

 

 

 

Columbia Short-Term Cash Fund, 0.115% (b)(c)

 

7,753,206

 

$

7,753,206

 

Total Money Market Funds
(Cost: $7,753,206)

 

 

 

$

7,753,206

 

Total Investments

 

 

 

 

 

(Cost: $219,506,132) (d)

 

 

 

$

266,314,610(e)

 

Other Assets & Liabilities, Net

 

 

 

(493,870)

 

Net Assets

 

 

 

$

265,820,740

 


 


 

Investments in Derivatives

Forward Foreign Currency Exchange Contracts Open at December 31, 2014   

 

 

Counterparty

 

Exchange
Date

 

Currency to be
Delivered

 

Delivered

 

Currency to be
Received

 

Received

 

Unrealized
Appreciation ($)

 

Unrealized
Depreciation ($)

 

Morgan Stanley & Co.

 

02/12/15

 

51,302,000

 

CNY

 

8,317,255

 

USD

 

 

(7,277

)

Morgan Stanley & Co.

 

02/12/15

 

3,336,263,000

 

IDR

 

266,241

 

USD

 

 

(450

)

Morgan Stanley & Co.

 

02/12/15

 

333,560,000

 

INR

 

5,238,888

 

USD

 

1,187

 

 

Morgan Stanley & Co.

 

02/12/15

 

25,681,000

 

INR

 

399,543

 

USD

 

 

(3,711

)

Morgan Stanley & Co.

 

02/12/15

 

653,877,000

 

JPY

 

5,488,538

 

USD

 

27,776

 

 

Morgan Stanley & Co.

 

02/12/15

 

256,005,000

 

PHP

 

5,705,483

 

USD

 

 

(5,339

)

Morgan Stanley & Co.

 

02/12/15

 

48,002,000

 

THB

 

1,445,613

 

USD

 

 

(10,508

)

Morgan Stanley & Co.

 

02/12/15

 

531,386

 

USD

 

656,000

 

AUD

 

2,676

 

 

Morgan Stanley & Co.

 

02/12/15

 

9,605,302

 

USD

 

10,580,526,000

 

KRW

 

49,576

 

 

Morgan Stanley & Co.

 

02/12/15

 

2,348,951

 

USD

 

8,172,000

 

MYR

 

 

(23,066

)

Morgan Stanley & Co.

 

02/12/15

 

1,065,080

 

USD

 

33,805,000

 

TWD

 

3,996

 

 

Morgan Stanley & Co.

 

02/12/15

 

5,168,654

 

USD

 

162,319,000

 

TWD

 

 

(35,350

)

Total

 

 

 

 

 

 

 

 

 

 

 

85,211

 

(85,701

)

 

Notes to Portfolio of Investments

 

 

(a)

Non-income producing.

(b)

The rate shown is the seven-day current annualized yield at December 31, 2014.

(c)

As defined in the Investment Company Act of 1940, an affiliated company is one in which the Fund owns 5% or more of the company’s outstanding voting securities, or a company which is under common ownership or control with the Fund. Holdings and transactions in these affiliated companies during the period ended December 31, 2014, are as follows:

 

Issuer

 

Beginning
Cost ($)

 

Purchase
Cost ($)

 

Proceeds From
Sales ($)

 

Ending Cost ($)

 

Dividends —
Affiliated Issuers ($)

 

Value ($)

 

Columbia Short-Term Cash Fund

 

1,349,698

 

80,993,689

 

(74,590,181

)

7,753,206

 

3,857

 

7,753,206

 

 

(d)

At December 31, 2014, the cost of securities for federal income tax purposes was approximately $219,506,000 and the approximate aggregate gross unrealized appreciation and depreciation based on that cost was:

 

Unrealized Appreciation

 

 

53,284,000

 

Unrealized Depreciation

 

(6,475,000

)

Net Unrealized Appreciation

 

 

46,809,000

 

 

(e)

Investments are valued using policies described in the notes to financial statements in the most recent shareholder report.

 

Abbreviation Legend

 

 

ADR

American Depositary Receipt

ADS

American Depositary Share

 

Currency Legend

 

 

AUD

Australian Dollar

CNY

China, Yuan Renminbi

IDR

Indonesian Rupiah

INR

Indian Rupee

JPY

Japanese Yen

KRW

Korean Won

MYR

Malaysia Ringgits

PHP

Philippine Peso

THB

Thailand Baht

TWD

Taiwan Dollar

USD

US Dollar

 

Fair Value Measurements

 

 

Generally accepted accounting principles (GAAP) require disclosure regarding the inputs and valuation techniques used to measure fair value and any changes in valuation inputs or techniques. In addition, investments shall be disclosed by major category.

 


 

The Fund categorizes its fair value measurements according to a three-level hierarchy that maximizes the use of observable inputs and minimizes the use of unobservable inputs by prioritizing that the most observable input be used when available.  Observable inputs are those that market participants would use in pricing an investment based on market data obtained from sources independent of the reporting entity. Unobservable inputs are those that reflect the Fund’s assumptions about the information market participants would use in pricing an investment. An investment’s level within the fair value hierarchy is based on the lowest level of any input that is deemed significant to the asset or liability’s fair value measurement. The input levels are not necessarily an indication of the risk or liquidity associated with investments at that level. For example, certain U.S. government securities are generally high quality and liquid, however, they are reflected as Level 2 because the inputs used to determine fair value may not always be quoted prices in an active market.

 

Fair value inputs are summarized in the three broad levels listed below:

 

·                  Level 1 - Valuations based on quoted prices for investments in active markets that the Fund has the ability to access at the measurement date (including NAV for open-end mutual funds).  Valuation adjustments are not applied to Level 1 investments.

 

·                  Level 2 – Valuations based on other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risks, etc.).

 

·                  Level 3 – Valuations based on significant unobservable inputs (including the Fund’s own assumptions and judgment in determining the fair value of investments).

 

Inputs that are used in determining fair value of an investment may include price information, credit data, volatility statistics, and other factors. These inputs can be either observable or unobservable. The availability of observable inputs can vary between investments, and is affected by various factors such as the type of investment, and the volume and level of activity for that investment or similar investments in the marketplace. The inputs will be considered by the Investment Manager, along with any other relevant factors in the calculation of an investment’s fair value. The Fund uses prices and inputs that are current as of the measurement date, which may include periods of market dislocations. During these periods, the availability of prices and inputs may be reduced for many investments. This condition could cause an investment to be reclassified between the various levels within the hierarchy.

 

Foreign equity securities actively traded in markets where there is a significant delay in the local close relative to the New York Stock Exchange (NYSE) are classified as Level 2.  The values of these securities may include an adjustment to reflect the impact of significant market movements following the close of local trading, as described in Note 2 to the financial statements — Security Valuation in the most recent Semiannual Report dated September 30, 2014.

 

Investments falling into the Level 3 category are primarily supported by quoted prices from brokers and dealers participating in the market for those investments.  However, these may be classified as Level 3 investments due to lack of market transparency and corroboration to support these quoted prices.  Additionally, valuation models may be used as the pricing source for any remaining investments classified as Level 3. These models may rely on one or more significant unobservable inputs and/or significant assumptions by the Investment Manager.  Inputs used in valuations may include, but are not limited to, financial statement analysis, capital account balances, discount rates and estimated cash flows, and comparable company data.

 

Under the direction of the Fund’s Board of Trustees (the Board), the Investment Manager’s Valuation Committee (the Committee) is responsible for overseeing the valuation procedures approved by the Board. The Committee consists of voting and non-voting members from various groups within the Investment Manager’s organization, including operations and accounting, trading and investments, compliance, risk management and legal.

 

The Committee meets at least monthly to review and approve valuation matters, which may include a description of specific valuation determinations, data regarding pricing information received from approved pricing vendors and brokers and the results of Board-approved valuation control policies and procedures (the Policies).  The Policies address, among other things, instances when market quotations are or are not readily available, including recommendations of third party pricing vendors and a determination of appropriate pricing methodologies; events that require specific valuation determinations and assessment of fair value techniques; securities with a potential for stale pricing, including those that are illiquid, restricted, or in default; and the effectiveness of third party pricing vendors, including periodic reviews of vendors.  The Committee meets more frequently, as needed, to discuss additional valuation matters, which may include the need to review back-testing results, review time-sensitive information or approve related valuation actions.  The Committee reports to the Board, with members of the Committee meeting with the Board at each of its regularly scheduled meetings to discuss valuation matters and actions during the period, similar to those described earlier.

 

For investments categorized as Level 3, the Committee monitors information similar to that described above, which may include: (i) data specific to the issuer or comparable issuers, (ii) general market or specific sector news and (iii) quoted prices and specific or similar security transactions. The Committee considers this data and any changes from prior periods in order to assess the reasonableness of observable and unobservable inputs, any assumptions or internal models used to value those securities and changes in fair value.  This data is also used to corroborate, when available, information received from approved pricing vendors and brokers.  Various factors impact the frequency of monitoring this information (which may occur as often as daily). However, the Committee may determine that changes to inputs, assumptions and models are not required as a result of the monitoring procedures performed.

 

The following table is a summary of the inputs used to value the Fund’s investments at December 31, 2014:

 


 

Description

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

 

 

 

 

 

Quoted Prices in

 

 

Other Significant

 

 

Significant

 

 

 

 

 

 

 

Active Markets for

 

 

Observable

 

 

Unobservable

 

 

 

 

 

 

 

Identical Assets ($)

 

 

Inputs ($)

 

 

Inputs ($)

 

 

Total ($)

 

Equity Securities

 

 

 

 

 

 

 

 

 

 

 

 

 

Common Stocks

 

 

 

 

 

 

 

 

 

 

 

 

 

Consumer Discretionary

 

 

1,244,620

 

 

32,829,828

 

 

 

 

34,074,448

 

Consumer Staples

 

 

 

 

7,672,052

 

 

 

 

7,672,052

 

Energy

 

 

 

 

2,435,257

 

 

 

 

2,435,257

 

Financials

 

 

3,432,730

 

 

71,171,199

 

 

 

 

74,603,929

 

Health Care

 

 

4,821,657

 

 

16,082,421

 

 

 

 

20,904,078

 

Industrials

 

 

 

 

32,491,853

 

 

 

 

32,491,853

 

Information Technology

 

 

8,441,216

 

 

36,699,220

 

 

 

 

45,140,436

 

Materials

 

 

 

 

9,434,909

 

 

 

 

9,434,909

 

Telecommunication Services

 

 

 

 

19,384,410

 

 

 

 

19,384,410

 

Utilities

 

 

 

 

9,048,762

 

 

 

 

9,048,762

 

Exchange-Traded Funds

 

 

3,371,270

 

 

 

 

 

 

3,371,270

 

Total Equity Securities

 

 

21,311,493

 

 

237,249,911

 

 

 

 

258,561,404

 

Mutual Funds

 

 

 

 

 

 

 

 

 

 

 

 

 

Money Market Funds

 

 

7,753,206

 

 

 

 

 

 

7,753,206

 

Total Mutual Funds

 

 

7,753,206

 

 

 

 

 

 

7,753,206

 

Investments in Securities

 

 

29,064,699

 

 

237,249,911

 

 

 

 

266,314,610

 

Derivatives

 

 

 

 

 

 

 

 

 

 

 

 

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

 

Forward Foreign Currency Exchange Contracts

 

 

 

 

85,211

 

 

 

 

85,211

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

Forward Foreign Currency Exchange Contracts

 

 

 

 

(85,701

)

 

 

 

(85,701

)

Total

 

 

29,064,699

 

 

237,249,421

 

 

 

 

266,314,120

 

 

See the Portfolio of Investments for all investment classifications not indicated in the table.

 

The Fund’s assets assigned to the Level 2 input category are generally valued using the market approach, in which a security’s value is determined through reference to prices and information from market transactions for similar or identical assets.  These assets include certain foreign securities for which a third party statistical pricing service may be employed for purposes of fair market valuation.  The model utilized by such third party statistical pricing service takes into account a security’s correlation to available market data including, but not limited to, intraday index, ADR, and ETF movements.

 

There were no transfers of financial assets between levels during the period.

 

Derivative instruments are valued at unrealized appreciation (depreciation).


 

Portfolio of Investments

Columbia Select Large Cap Growth Fund

 

December 31, 2014 (Unaudited)

 

(Percentages represent value of investments compared to net assets)


 

Issuer

 

Shares

 

Value

 

 

 

 

 

 

 

Common Stocks 99.7%

 

 

 

 

 

CONSUMER DISCRETIONARY 20.2%

 

 

 

 

 

Automobiles 2.4%

 

 

 

 

 

Tesla Motors, Inc. (a)

 

723,257

 

$

160,859,589

 

Internet & Catalog Retail 8.8%

 

 

 

 

 

Amazon.com, Inc. (a)

 

879,098

 

272,828,064

 

Priceline Group, Inc. (The) (a)

 

291,427

 

332,287,980

 

Total

 

 

 

605,116,044

 

Specialty Retail 3.0%

 

 

 

 

 

Tractor Supply Co.

 

2,584,128

 

203,680,969

 

Textiles, Apparel & Luxury Goods 6.0%

 

 

 

 

 

Michael Kors Holdings Ltd. (a)

 

2,795,063

 

209,909,231

 

Nike, Inc., Class B

 

2,093,640

 

201,303,486

 

Total

 

 

 

411,212,717

 

TOTAL CONSUMER DISCRETIONARY

 

 

 

1,380,869,319

 

ENERGY 5.9%

 

 

 

 

 

Energy Equipment & Services 2.2%

 

 

 

 

 

FMC Technologies, Inc. (a)

 

3,242,129

 

151,861,323

 

Oil, Gas & Consumable Fuels 3.7%

 

 

 

 

 

Cabot Oil & Gas Corp.

 

8,543,230

 

252,965,040

 

TOTAL ENERGY

 

 

 

404,826,363

 

HEALTH CARE 25.8%

 

 

 

 

 

Biotechnology 18.0%

 

 

 

 

 

Alexion Pharmaceuticals, Inc. (a)

 

984,834

 

182,223,835

 

Biogen Idec, Inc. (a)

 

765,452

 

259,832,681

 

Celgene Corp. (a)

 

2,338,942

 

261,634,052

 

Pharmacyclics, Inc. (a)

 

2,165,240

 

264,722,243

 

Vertex Pharmaceuticals, Inc. (a)

 

2,227,395

 

264,614,526

 

Total

 

 

 

1,233,027,337

 

Life Sciences Tools & Services 4.3%

 

 

 

 

 

Illumina, Inc. (a)

 

1,575,672

 

290,837,538

 

Pharmaceuticals 3.5%

 

 

 

 

 

Bristol-Myers Squibb Co.

 

4,051,733

 

239,173,799

 

TOTAL HEALTH CARE

 

 

 

1,763,038,674

 

 

Issuer

 

Shares

 

Value

 

 

 

 

 

 

 

Common Stocks (continued)

 

 

INDUSTRIALS 6.3%

 

 

 

 

 

Aerospace & Defense 2.5%

 

 

 

 

 

Precision Castparts Corp.

 

702,205

 

$

169,147,140

 

Trading Companies & Distributors 3.8%

 

 

 

 

 

Fastenal Co.

 

5,544,326

 

263,688,145

 

TOTAL INDUSTRIALS

 

 

 

432,835,285

 

INFORMATION TECHNOLOGY 38.8%

 

 

 

 

 

Internet Software & Services 19.3%

 

 

 

 

 

Alibaba Group Holding Ltd., ADR (a)

 

1,307,004

 

135,849,996

 

Baidu, Inc., ADR (a)

 

1,081,325

 

246,509,660

 

Facebook, Inc., Class A (a)

 

3,142,343

 

245,165,601

 

LinkedIn Corp., Class A (a)

 

1,362,056

 

312,877,884

 

MercadoLibre, Inc. (b)

 

1,239,918

 

158,300,331

 

Twitter, Inc. (a)

 

6,176,268

 

221,542,733

 

Total

 

 

 

1,320,246,205

 

IT Services 6.9%

 

 

 

 

 

Cognizant Technology Solutions Corp., Class A (a)

 

4,041,896

 

212,846,243

 

Visa, Inc., Class A

 

1,002,164

 

262,767,401

 

Total

 

 

 

475,613,644

 

Semiconductors & Semiconductor Equipment 3.3%

 

ARM Holdings PLC, ADR

 

4,827,610

 

223,518,343

 

Software 9.3%

 

 

 

 

 

salesforce.com, Inc. (a)

 

4,237,516

 

251,327,074

 

Splunk, Inc. (a)

 

3,421,373

 

201,689,938

 

VMware, Inc., Class A (a)

 

2,260,300

 

186,519,956

 

Total

 

 

 

639,536,968

 

TOTAL INFORMATION TECHNOLOGY

 

 

 

2,658,915,160

 

MATERIALS 2.7%

 

 

 

 

 

Chemicals 2.7%

 

 

 

 

 

Monsanto Co.

 

1,549,985

 

185,176,708

 

TOTAL MATERIALS

 

 

 

185,176,708

 

Total Common Stocks
(Cost: $4,538,384,951)

 

 

 

$

6,825,661,509

 

 



 

 

 

Shares

 

Value

 

 

 

 

 

 

 

Money Market Funds 0.3%

 

 

 

 

 

Columbia Short-Term Cash Fund, 0.115% (b)(c)

 

22,021,533

 

$

22,021,533

 

Total Money Market Funds
(Cost: $22,021,533)

 

 

 

$

22,021,533

 

 

Total Investments

 

 

 

 

 

(Cost: $4,560,406,484) (d)

 

 

 

$

6,847,683,042(e)

 

Other Assets & Liabilities, Net

 

 

 

104,062

 

Net Assets

 

 

 

$

6,847,787,104

 


 

Notes to Portfolio of Investments

 

 

(a)

Non-income producing.

(b)

As defined in the Investment Company Act of 1940, an affiliated company is one in which the Fund owns 5% or more of the company’s outstanding voting securities, or a company which is under common ownership or control with the Fund. Holdings and transactions in these affiliated companies during the period ended December 31, 2014, are as follows:

 

Issuer

 

Beginning
Cost ($)

 

Purchase Cost ($)

 

Proceeds From
Sales ($)

 

Realized Gain
(Loss) ($)

 

Ending Cost ($)

 

Dividends
— Affiliated
Issuers ($)

 

Value ($)

 

Columbia Short-Term Cash Fund

 

112,206,652

 

1,507,205,853

 

(1,597,390,972

)

 

22,021,533

 

64,570

 

22,021,533

 

Mercadolibre Inc. *

 

272,572,884

 

147,458,188

 

(206,226,819

)

(71,138,138

)

142,666,115

 

578,876

 

158,300,331

 

Total

 

384,779,536

 

1,654,664,041

 

(1,803,617,791

)

(71,138,138

)

164,687,648

 

643,446

 

180,321,864

 

 

 

* Issuer was not an affiliate for the entire period ended December 31, 2014.

 

 

(c)

The rate shown is the seven-day current annualized yield at December 31, 2014.

(d)

At December 31, 2014, the cost of securities for federal income tax purposes was approximately $4,560,406,000 and the approximate aggregate gross unrealized appreciation and depreciation based on that cost was:

 

Unrealized Appreciation

 

$

2,405,947,000

 

Unrealized Depreciation

 

(118,670,000

)

Net Unrealized Appreciation

 

$

2,287,277,000

 

 

(e)

Investments are valued using policies described in the notes to financial statements in the most recent shareholder report.

 

Abbreviation Legend

 

 

ADR

American Depositary Receipt

 

Fair Value Measurements

 

 

Generally accepted accounting principles (GAAP) require disclosure regarding the inputs and valuation techniques used to measure fair value and any changes in valuation inputs or techniques. In addition, investments shall be disclosed by major category.

 

The Fund categorizes its fair value measurements according to a three-level hierarchy that maximizes the use of observable inputs and minimizes the use of unobservable inputs by prioritizing that the most observable input be used when available.  Observable inputs are those that market participants would use in pricing an investment based on market data obtained from sources independent of the reporting entity. Unobservable inputs are those that reflect the Fund’s assumptions about the information market participants would use in pricing an investment. An investment’s level within the fair value hierarchy is based on the lowest level of any input that is deemed significant to the asset or liability’s fair value measurement. The input levels are not necessarily an indication of the risk or liquidity associated with investments at that level. For example, certain U.S. government securities are generally high quality and liquid, however, they are reflected as Level 2 because the inputs used to determine fair value may not always be quoted prices in an active market.

 

Fair value inputs are summarized in the three broad levels listed below:

 

·                   Level 1 - Valuations based on quoted prices for investments in active markets that the Fund has the ability to access at the measurement date (including NAV for open-end mutual funds).  Valuation adjustments are not applied to Level 1 investments.

 

·                   Level 2 – Valuations based on other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risks, etc.).

 

·                   Level 3 – Valuations based on significant unobservable inputs (including the Fund’s own assumptions and judgment in determining the fair value of investments).

 


 

Inputs that are used in determining fair value of an investment may include price information, credit data, volatility statistics, and other factors. These inputs can be either observable or unobservable. The availability of observable inputs can vary between investments, and is affected by various factors such as the type of investment, and the volume and level of activity for that investment or similar investments in the marketplace. The inputs will be considered by the Investment Manager, along with any other relevant factors in the calculation of an investment’s fair value. The Fund uses prices and inputs that are current as of the measurement date, which may include periods of market dislocations. During these periods, the availability of prices and inputs may be reduced for many investments. This condition could cause an investment to be reclassified between the various levels within the hierarchy.

 

Investments falling into the Level 3 category are primarily supported by quoted prices from brokers and dealers participating in the market for those investments.  However, these may be classified as Level 3 investments due to lack of market transparency and corroboration to support these quoted prices.  Additionally, valuation models may be used as the pricing source for any remaining investments classified as Level 3. These models may rely on one or more significant unobservable inputs and/or significant assumptions by the Investment Manager.  Inputs used in valuations may include, but are not limited to, financial statement analysis, capital account balances, discount rates and estimated cash flows, and comparable company data.

 

Under the direction of the Fund’s Board of Trustees (the Board), the Investment Manager’s Valuation Committee (the Committee) is responsible for overseeing the valuation procedures approved by the Board. The Committee consists of voting and non-voting members from various groups within the Investment Manager’s organization, including operations and accounting, trading and investments, compliance, risk management and legal.

 

The Committee meets at least monthly to review and approve valuation matters, which may include a description of specific valuation determinations, data regarding pricing information received from approved pricing vendors and brokers and the results of Board-approved valuation control policies and procedures (the Policies).  The Policies address, among other things, instances when market quotations are or are not readily available, including recommendations of third party pricing vendors and a determination of appropriate pricing methodologies; events that require specific valuation determinations and assessment of fair value techniques; securities with a potential for stale pricing, including those that are illiquid, restricted, or in default; and the effectiveness of third party pricing vendors, including periodic reviews of vendors.  The Committee meets more frequently, as needed, to discuss additional valuation matters, which may include the need to review back-testing results, review time-sensitive information or approve related valuation actions.  The Committee reports to the Board, with members of the Committee meeting with the Board at each of its regularly scheduled meetings to discuss valuation matters and actions during the period, similar to those described earlier.

 

For investments categorized as Level 3, the Committee monitors information similar to that described above, which may include: (i) data specific to the issuer or comparable issuers, (ii) general market or specific sector news and (iii) quoted prices and specific or similar security transactions.  The Committee considers this data and any changes from prior periods in order to assess the reasonableness of observable and unobservable inputs, any assumptions or internal models used to value those securities and changes in fair value.  This data is also used to corroborate, when available, information received from approved pricing vendors and brokers. Various factors impact the frequency of monitoring this information (which may occur as often as daily). However, the Committee may determine that changes to inputs, assumptions and models are not required as a result of the monitoring procedures performed.

 

The following table is a summary of the inputs used to value the Fund’s investments at December 31, 2014:

 

Description

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

 

 

 

 

 

Quoted Prices in

 

 

Other Significant

 

 

Significant

 

 

 

 

 

 

 

Active Markets for

 

 

Observable

 

 

Unobservable

 

 

 

 

 

 

 

Identical Assets ($)

 

 

Inputs ($)

 

 

Inputs ($)

 

 

Total ($)

 

Equity Securities

 

 

 

 

 

 

 

 

 

 

 

 

 

Common Stocks

 

 

 

 

 

 

 

 

 

 

 

 

 

Consumer Discretionary

 

 

1,380,869,319

 

 

 

 

 

 

1,380,869,319

 

Energy

 

 

404,826,363

 

 

 

 

 

 

404,826,363

 

Health Care

 

 

1,763,038,674

 

 

 

 

 

 

1,763,038,674

 

Industrials

 

 

432,835,285

 

 

 

 

 

 

432,835,285

 

Information Technology

 

 

2,658,915,160

 

 

 

 

 

 

2,658,915,160

 

Materials

 

 

185,176,708

 

 

 

 

 

 

185,176,708

 

Total Equity Securities

 

 

6,825,661,509

 

 

 

 

 

 

6,825,661,509

 

Mutual Funds

 

 

 

 

 

 

 

 

 

 

 

 

 

Money Market Funds

 

 

22,021,533

 

 

 

 

 

 

22,021,533

 

Total Mutual Funds

 

 

22,021,533

 

 

 

 

 

 

22,021,533

 

Total

 

 

6,847,683,042

 

 

 

 

 

 

6,847,683,042

 

 

See the Portfolio of Investments for all investment classifications not indicated in the table.

 

There were no transfers of financial assets between levels during the period.


 

Item  2. Controls and Procedures.

 

(a)         The registrant’s principal executive officer and principal financial officers, based on their evaluation of the registrant’s disclosure controls and procedures as of a date within 90 days of the filing of this report, have concluded that such controls and procedures are adequately designed to ensure that information required to be disclosed by the registrant in Form N-Q is accumulated and communicated to the registrant’s management, including the principal executive officer and principal financial officer, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

 

(b)         There was no change in the registrant’s internal control over financial reporting that occurred during the registrant’s last fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

 

Item 3. Exhibits.

 

Certifications pursuant to Rule 30a-2(a) under the Investment Company Act of 1940 (17 CFR 270.30a-2(a)) attached hereto as Exhibit 99.CERT.

 



 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

(registrant)

 

Columbia Funds Series Trust I

 

 

 

 

 

 

By (Signature and Title)

 

/s/ Christopher O. Petersen

 

Christopher O. Petersen, President and Principal Executive Officer

 

 

 

 

Date

 

February 23, 2015

 

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

By (Signature and Title)

 

/s/ Christopher O. Petersen

 

Christopher O. Petersen, President and Principal Executive Officer

 

 

 

 

Date

 

February 23, 2015

 

 

 

 

By (Signature and Title)

 

/s/ Michael G. Clarke

 

 

Michael G. Clarke, Treasurer and Chief Financial Officer

 

 

 

 

Date

 

February 23, 2015

 


EX-99.CERT 2 a15-2258_1ex99dcert.htm EX-99.CERT

Exhibit 99.CERT

 

I, Michael G. Clarke, certify that:

 

1.                                      I have reviewed this report on Form N-Q of Columbia Funds Series Trust I;

 

2.                                      Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.                                      Based on my knowledge, the schedules of investments included in this report fairly present in all material respects the investments of the registrant as of the end of the fiscal quarter for which the report is filed;

 

4.                                      The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:

 

(a)                                 designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)                                 designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)                                  evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report based on such evaluation; and

 

(d)                                 disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.                                      The registrant’s other certifying officer(s) and I have disclosed to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a)                                 all significant deficiencies and material weaknesses  in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize, and report financial information; and

 

(b)                                 any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

 

Date:

February 23, 2015

/s/ Michael G. Clarke

 

 

Michael G. Clarke, Treasurer and Chief Financial Officer

 



 

I, Christopher O. Petersen, certify that:

 

1.                                      I have reviewed this report on Form N-Q of Columbia Funds Series Trust I;

 

2.                                      Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.                                      Based on my knowledge, the schedules of investments included in this report fairly present in all material respects the investments of the registrant as of the end of the fiscal quarter for which the report is filed;

 

4.                                      The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:

 

(a)                                 designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)                                 designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)                                  evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report based on such evaluation; and

 

(d)                                 disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.                                      The registrant’s other certifying officer(s) and I have disclosed to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a)                                 all significant deficiencies and material weaknesses  in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize, and report financial information; and

 

(b)                                 any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

 

Date:

February 23, 2015

/s/ Christopher O. Petersen

 

 

Christopher O. Petersen, President and Principal Executive Officer